Patents Assigned to Vector Vitale IP LLC
  • Patent number: 11896610
    Abstract: Engineered food to promote health and maintain homeostasis in a subject and methods of producing the food.
    Type: Grant
    Filed: July 21, 2022
    Date of Patent: February 13, 2024
    Assignee: Vector Vitale IP LLC
    Inventors: Peter Y. Novak, Maxim V. Temnikov
  • Publication number: 20230381347
    Abstract: A method for treating melanoma or preventing the development of melanoma comprising administration of a composition comprising 64Zne(Asp)2 in a therapeutically effective amount. Such administration may be via injection such as intratumoral and/or intravenous injection and may be once a day or more than once a day. A composition for the treatment of or prevention of melanoma comprising 64Zne(Asp)2 in a therapeutically effective amount. The composition may be a liquid suitable for injection.
    Type: Application
    Filed: August 9, 2023
    Publication date: November 30, 2023
    Applicant: Vector Vitale IP LLC
    Inventors: Peter NOVAK, Max TEMNIK, Oleksandr BALAKIN
  • Patent number: 11827588
    Abstract: Novel 85Rb-enriched rubidium salt compounds of general formula 1, below and novel compounds of general formula 2, below. Compositions that contain at least one of the novel compounds and optionally further contain an antitumor drug. Methods that entail administering such compounds and compositions to treat cancer, optionally in combination with a conventional form of cancer therapy, such as chemotherapy and radiation treatment. When administered with a conventional form of cancer therapy, the compounds and compositions of the invention may be administered before, simultaneously with, or after administration of the conventional form of cancer therapy.
    Type: Grant
    Filed: March 16, 2022
    Date of Patent: November 28, 2023
    Assignee: Vector Vitale IP LLC
    Inventors: Peter Novak, Maxim Temnikov, Oleksandr Balakin
  • Patent number: 11779597
    Abstract: Compositions that comprise salts, compounds and complexes of 64Zn-enriched zinc, such as 64Zn-enriched zinc aspartate, and further optionally include 85Rb-enriched rubidium salt compounds of general formula 1, below, wherein each of R1 through R14 is independently selected from H, OH, F, Cl, Br, I, C1-C6 alkyl, C1-C6 alkoxy, and NO2, such as the compound of Formula 1 in which R3 is CH3 and all other R groups are H for use to treat a neurodegenerative disease (NDD), such as Parkinson's disease (PD). Methods that entail administering such compositions to treat an NDD, such as PD, optionally in combination with any other treatment for an NDD such as for PD.
    Type: Grant
    Filed: October 11, 2019
    Date of Patent: October 10, 2023
    Assignee: Vector Vitale IP LLC
    Inventors: Peter Novak, Maxim Temnikov, Oleksandr Balakin
  • Patent number: 11730835
    Abstract: A method for treating melanoma or preventing the development of melanoma comprising administration of a composition comprising 64Zne(Asp)2 in a therapeutically effective amount. Such administration may be via injection such as intratumoral and/or intravenous injection and may be once a day or more than once a day. A composition for the treatment of or prevention of melanoma comprising 64Zne(Asp)2 in a therapeutically effective amount. The composition may be a liquid suitable for injection.
    Type: Grant
    Filed: October 19, 2022
    Date of Patent: August 22, 2023
    Assignee: Vector Vitale IP LLC
    Inventors: Peter Novak, Maxim V. Temnikov, Oleksandr Balakin
  • Publication number: 20230218665
    Abstract: An antibacterial composition that comprises as active compound at least one light isotope of an element selected from the group which consists of 1H, 12C, 16O, 14N, 39K, 24Mg, 64Zn, 85Rb, 28Si, 54Fe, 92Mo, 74Se, 58Ni, 70Ge, 52Cr, 63Cu, 50V, or combinations thereof, wherein the composition is enriched for the at least one light isotope. A method of treating and preventing bacterial diseases in humans and non-human animals by administering the composition. The use of the said composition in human and veterinary medicine for the prevention and treatment of diseases in humans and non-human animals and also as an antiseptic and disinfectant.
    Type: Application
    Filed: January 23, 2023
    Publication date: July 13, 2023
    Applicant: Vector Vitale IP LLC
    Inventors: Peter Y. NOVAK, Maxim V. TEMNIKOV, Oleksandr BALAKIN
  • Publication number: 20230210894
    Abstract: Compositions that comprise salts, compounds and complexes of 64Zn-enriched zinc, such as 64Zn-enriched zinc aspartate, and further optionally include 85Rb-enriched rubidium salt compounds of general formula 1, below, wherein each of R1 through R14 is independently selected from H, OH, F, Cl, Br, I, C1-C6 alkyl, C1-C6 alkoxy, and NO2, such as the compound of Formula 1 in which R3 is CH3 and all other R groups are H for use to treat a neurodegenerative disease (NDD), such as Parkinson's disease (PD). Methods that entail administering such compositions to treat an NDD, such as PD, optionally in combination with any other treatment for an NDD such as for PD.
    Type: Application
    Filed: October 11, 2019
    Publication date: July 6, 2023
    Applicant: Vector Vitale IP LLC
    Inventors: Peter NOVAK, Maxim TEMNIKOV, Oleksandr BALAKIN
  • Patent number: 11638721
    Abstract: An antibacterial composition that comprises as active compound at least one light isotope of an element selected from the group which consists of 1H, 12C, 16O, 14N, 39K, 24Mg, 64Zn, 85Rb, 28Si, 54Fe, 92Mo, 74Se, 58Ni, 70Ge, 52Cr, 63Cu, 50V, or combinations thereof, wherein the composition is enriched for the at least one light isotope. A method of treating and preventing bacterial diseases in humans and non-human animals by administering the composition. The use of the said composition in human and veterinary medicine for the prevention and treatment of diseases in humans and non-human animals and also as an antiseptic and disinfectant.
    Type: Grant
    Filed: December 5, 2018
    Date of Patent: May 2, 2023
    Assignee: Vector Vitale IP LLC
    Inventors: Peter Y. Novak, Maxim V. Temnikov, Oleksandr Balakin
  • Patent number: 11596650
    Abstract: A method of preventing or treating type 2 diabetes comprising administering a therapeutically effective amount of 64Zn-enriched zinc.
    Type: Grant
    Filed: December 20, 2019
    Date of Patent: March 7, 2023
    Assignee: Vector Vitale IP LLC
    Inventors: Peter Novak, Maxim Temnikov, Oleksandr Balakin
  • Publication number: 20230061538
    Abstract: A pharmaceutical composition of the present invention is used for improving health, cure abnormalities and degenerative disease; achieve anti-aging effect of therapy and therapeutic effect on mammals. The pharmaceutical composition includes a pharmaceutical carrier and an isotope selective ingredient including at least one of a chemical element and a chemical compound containing the chemical element whereby isotope distribution in the at least one of the chemical element and the chemical compound containing the chemical element is different from natural distribution of at least one of isotopes wherein the part of selected isotope of the chemical element ranges from 0 to 100%. A method of the present invention uses the inventive pharmaceutical composition to improve health, cure abnormalities and degenerative disease and achieve therapeutic effect on mammals.
    Type: Application
    Filed: October 19, 2022
    Publication date: March 2, 2023
    Applicant: Vector Vitale IP LLC
    Inventors: Peter Y. Novak, Maxim V. Temnikov, Oleksandr Balakin
  • Publication number: 20230050325
    Abstract: A method for treating melanoma or preventing the development of melanoma comprising administration of a composition comprising 64Zne(Asp)2 in a therapeutically effective amount. Such administration may be via injection such as intratumoral and/or intravenous injection and may be once a day or more than once a day. A composition for the treatment of or prevention of melanoma comprising 64Zne(Asp)2 in a therapeutically effective amount. The composition may be a liquid suitable for injection.
    Type: Application
    Filed: October 19, 2022
    Publication date: February 16, 2023
    Applicant: Vector Vitale IP LLC
    Inventors: Peter NOVAK, Maxim V. TEMNIKOV, Oleksandr BALAKIN
  • Patent number: 11559546
    Abstract: An antibacterial composition that comprises as active compound at least one light isotope of an element selected from the group which consists of 1H, 12C, 16O, 14N, 39K, 24Mg, 64Zn, 85Rb, 28Si, 54Fe, 92Mo, 74Se, 58Ni, 70Ge, 52Cr, 63Cu, 50V, or combinations thereof, wherein the composition is enriched for the at least one light isotope. A method of treating and preventing bacterial diseases in humans and non-human animals by administering the composition. The use of the said composition in human and veterinary medicine for the prevention and treatment of diseases in humans and non-human animals and also as an antiseptic and disinfectant.
    Type: Grant
    Filed: December 5, 2018
    Date of Patent: January 24, 2023
    Assignee: Vector Vitale IP LLC
    Inventors: Peter Y. Novak, Maxim V. Temnikov, Oleksandr Balakin
  • Publication number: 20220362287
    Abstract: Engineered food to promote health and maintain homeostasis in a subject and methods of producing the food.
    Type: Application
    Filed: July 21, 2022
    Publication date: November 17, 2022
    Applicant: Vector Vitale IP LLC
    Inventors: Peter Y. NOVAK, Maxim V. TEMNIKOV
  • Patent number: 11484550
    Abstract: A pharmaceutical composition of the present invention is used for improving health, cure abnormalities and degenerative disease; achieve anti-aging effect of therapy and therapeutic effect on mammals. The pharmaceutical composition includes a pharmaceutical carrier and an isotope selective ingredient including at least one of a chemical element and a chemical compound containing the chemical element whereby isotope distribution in the at least one of the chemical element and the chemical compound containing the chemical element is different from natural distribution of at least one of isotopes wherein the part of selected isotope of the chemical element ranges from 0 to 100%. A method of the present invention uses the inventive pharmaceutical composition to improve health, cure abnormalities and degenerative disease and achieve therapeutic effect on mammals.
    Type: Grant
    Filed: December 7, 2020
    Date of Patent: November 1, 2022
    Assignee: VECTOR VITALE IP LLC
    Inventors: Peter Novak, Maxim Temnikov, Oleksandr Balakin
  • Patent number: 11484610
    Abstract: A method for treating melanoma or preventing the development of melanoma comprising administration of a composition comprising 64Zne(Asp)2 in a therapeutically effective amount. Such administration may be via injection such as intratumoral and/or intravenous injection and may be once a day or more than once a day. A composition for the treatment of or prevention of melanoma comprising 64Zne(Asp)2 in a therapeutically effective amount. The composition may be a liquid suitable for injection.
    Type: Grant
    Filed: November 22, 2019
    Date of Patent: November 1, 2022
    Assignee: VECTOR VITALE IP LLC
    Inventors: Peter Novak, Maxim Temnikov, Oleksandr Balakin
  • Publication number: 20220313731
    Abstract: A method of treating or preventing Alzheimer's disease comprising administering a pharmaceutical composition comprising 64Zne or a salt thereof, at a therapeutically effective or a prophylactically effective dose for treating or preventing the disease.
    Type: Application
    Filed: March 26, 2021
    Publication date: October 6, 2022
    Applicant: Vector Vitale IP LLC
    Inventors: Peter Y. NOVAK, Maxim V. TEMNIKOV
  • Publication number: 20220305054
    Abstract: Engineered food to promote health and maintain homeostasis in a subject and methods of producing the food.
    Type: Application
    Filed: March 26, 2021
    Publication date: September 29, 2022
    Applicant: Vector Vitale IP LLC
    Inventors: Peter Y. NOVAK, Maxim V. TEMNIKOV
  • Patent number: 11433095
    Abstract: Engineered food to promote health and maintain homeostasis in a subject and methods of producing the food.
    Type: Grant
    Filed: March 26, 2021
    Date of Patent: September 6, 2022
    Assignee: VECTOR VITALE IP LLC
    Inventors: Peter Y. Novak, Maxim V. Temnikov
  • Publication number: 20220220070
    Abstract: Novel 85Rb-enriched rubidium salt compounds of general formula 1, below and novel compounds of general formula 2, below. Compositions that contain at least one of the novel compounds and optionally further contain an antitumor drug. Methods that entail administering such compounds and compositions to treat cancer, optionally in combination with a conventional form of cancer therapy, such as chemotherapy and radiation treatment. When administered with a conventional form of cancer therapy, the compounds and compositions of the invention may be administered before, simultaneously with, or after administration of the conventional form of cancer therapy.
    Type: Application
    Filed: March 16, 2022
    Publication date: July 14, 2022
    Applicant: Vector Vitale IP LLC
    Inventors: Peter Novak, Maxim Temnikov, Oleksandr Balakin
  • Patent number: 11286236
    Abstract: Novel 85Rb-enriched rubidium salt compounds of general formula 1, below and novel compounds of general formula 2, below. Compositions that contain at least one of the novel compounds and optionally further contain an antitumor drug. Methods that entail administering such compounds and compositions to treat cancer, optionally in combination with a conventional form of cancer therapy, such as chemotherapy and radiation treatment. When administered with a conventional form of cancer therapy, the compounds and compositions of the invention may be administered before, simultaneously with, or after administration of the conventional form of cancer therapy.
    Type: Grant
    Filed: May 29, 2019
    Date of Patent: March 29, 2022
    Assignee: VECTOR VITALE IP LLC
    Inventors: Peter Novak, Maxim Temnikov, Oleksandr Balakin